RediNews
ETFs Holding ABBV »    ABBV Historical Stock Prices »
ABBV News Video: Mon, Mar 26, 2018, 1:30 PM — Monday's ETF with Unusual Volume: XMX


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. Self directed investors in AbbVie will be interested in keeping up with all AbbVie news they can find, both ABBV news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ABBV. At RediNews, we simplify this task by presenting both ABBV news releases originating from AbbVie itself, and ABBV news from a variety of media outlets. Visitors can browse this news online and through our ABBV RSS news feed.

AbbVie News

AbbVie News — Articles, Videos, & Press Releases

J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?
Friday, April 20, 2018, 8:11 AM — Zacks
Roche Hemophilia Drug Gets Breakthrough Therapy Designation
Wednesday, April 18, 2018, 4:54 PM — Zacks
5 Drug Stocks Poised to Surpass on Earnings This Quarter
Tuesday, April 17, 2018, 9:48 AM — Zacks
J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance
Tuesday, April 17, 2018, 7:40 AM — Zacks
Shire Sells Oncology Unit Ahead of Takeda's Potential Offer
Tuesday, April 17, 2018, 6:59 AM — Zacks
Vanguard S&P 500 ETF Experiences Big Outflow
Monday, April 16, 2018, 10:56 AM — ETF Channel
Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings?
Friday, April 13, 2018, 9:04 AM — Zacks
Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar
Thursday, April 12, 2018, 3:53 PM — Zacks
J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store?
Thursday, April 12, 2018, 6:17 AM — Zacks
FDA Prolongs Review Date for AbbVie Endometriosis Candidate
Wednesday, April 11, 2018, 9:36 AM — Zacks
AbbVie's RA Candidate Meets Primary Endpoints in Phase III
Tuesday, April 10, 2018, 2:40 PM — Zacks
Ex-Dividend Reminder: American Eagle Outfitters, Buckle and AbbVie
Tuesday, April 10, 2018, 9:59 AM — Dividend Channel
iShares S&P 500 Growth ETF Experiences Big Outflow
Friday, April 6, 2018, 10:46 AM — ETF Channel
Biogen Cracks the Case With AbbVie for Humira Biosimilar
Friday, April 6, 2018, 9:06 AM — Zacks
Tuesday Sector Laggards: Utilities, Healthcare
Tuesday, April 3, 2018, 3:32 PM — Market News Video
Aeglea Initiates Lung Cancer Combination Study With Keytruda
Tuesday, April 3, 2018, 6:53 AM — Zacks
AbbVie Breaks Below 200-Day Moving Average - Notable for ABBV
Monday, April 2, 2018, 4:44 PM — Dividend Channel
Noteworthy ETF Inflows: IUSG, ABBV, BKNG, TXN
Thursday, March 29, 2018, 10:52 AM — ETF Channel
AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV)
Wednesday, March 28, 2018, 8:27 AM — ETF Channel
5 Dividend Aristocrats Where Analysts See Capital Gains
Friday, March 23, 2018, 10:27 AM — ETF Channel
The Implied Analyst 12-Month Target For SPMO
Friday, March 23, 2018, 8:27 AM — ETF Channel
AbbVie (ABBV) Stock Falls on Weak Lung Cancer Study Outcome
Friday, March 23, 2018, 5:10 AM — Zacks
AbbVie (ABBV) Shares Cross 4% Yield Mark
Thursday, March 22, 2018, 3:17 PM — Dividend Channel
RSI Alert: AbbVie (ABBV) Now Oversold
Thursday, March 22, 2018, 12:23 PM — Dividend Channel
Why Is AbbVie (ABBV) Stock Crashing Today?
Thursday, March 22, 2018, 9:32 AM — Zacks
iShares Core S&P Total U.S. Stock Market ETF Experiences Big Inflow
Wednesday, March 21, 2018, 11:03 AM — ETF Channel
J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit
Monday, March 19, 2018, 8:41 AM — Zacks
Why Multiple Sclerosis is a Promising but Risky Space?
Friday, March 16, 2018, 9:12 AM — Zacks
AbbVie's Uterine Fibroids Candidate Succeeds in Phase III
Wednesday, March 14, 2018, 9:15 AM — Zacks
The Best Marijuana Stocks Right Now
Wednesday, March 14, 2018, 9:06 AM — Zacks
VHT, ABBV, BMY, DHR: ETF Outflow Alert
Tuesday, March 13, 2018, 11:08 AM — ETF Channel
M&A, Innovation & New Drugs to Drive Pharma Stocks
Thursday, March 8, 2018, 4:00 PM — Zacks
Want to be a Buy and Hold Investor? 3 Strategies
Thursday, March 8, 2018, 9:29 AM — Zacks
Want to be a Buy and Hold Investor? 3 Strategies
Thursday, March 8, 2018, 9:26 AM — Zacks
Profit From Share Buyback Boom With These ETFs
Tuesday, March 6, 2018, 9:59 AM — Zacks
Gilead Announces Positive Data on New HIV Therapy Biktarvy
Tuesday, March 6, 2018, 6:52 AM — Zacks
Notable ETF Inflow Detected - MTUM, BA, ABBV, AMAT
Friday, March 2, 2018, 10:46 AM — ETF Channel
4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio
Wednesday, February 28, 2018, 8:06 AM — Zacks
Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP
Tuesday, February 27, 2018, 8:38 AM — Zacks
ABBV Crosses Above Average Analyst Target
Tuesday, February 27, 2018, 8:24 AM — ETF Channel
AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?
Monday, February 26, 2018, 4:57 AM — Zacks
New Strong Buy Stocks for February 23rd
Friday, February 23, 2018, 8:27 AM — Zacks
Abbvie's Uterine Fibrosis Candidate Meets Goal in Study
Thursday, February 22, 2018, 6:23 PM — Zacks
Notable ETF Inflow Detected - MTUM, BA, ABBV, C
Thursday, February 22, 2018, 11:11 AM — ETF Channel
Interesting ABBV Put And Call Options For April 20th
Thursday, February 22, 2018, 10:59 AM — Stock Options Channel
Novartis Psoriasis Drug Cosentyx Positive in SCALP Study
Tuesday, February 20, 2018, 7:27 AM — Zacks
AbbVie Presents New Data on Upadacitinib for Crohn's Disease
Monday, February 19, 2018, 9:04 AM — Zacks
AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan
Friday, February 16, 2018, 7:04 AM — Zacks
Lilly's Taltz Positive in Phase III Label Expansion Study
Wednesday, February 14, 2018, 8:47 AM — Zacks
Novartis' Cosentyx Label Expanded to Include Scalp Psoriasis
Thursday, February 8, 2018, 10:10 AM — Zacks
FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up
Thursday, February 8, 2018, 8:36 AM — Zacks
AbbVie Becomes #224 Most Shorted S&P 500 Component, Replacing Xylem
Thursday, February 8, 2018, 8:05 AM — Market News Video
Add These 7 GARP Stocks to Your Portfolio for Better Returns
Wednesday, February 7, 2018, 9:05 AM — Zacks
Gilead (GILD) Beats on Q4 Earnings, 2018 View Lacks Lustre
Wednesday, February 7, 2018, 8:02 AM — Zacks
Why AbbVie is a Top 25 Dividend Giant (ABBV)
Wednesday, February 7, 2018, 7:56 AM — ETF Channel
Notable ETF Inflow Detected - MTUM, BA, ABBV, PYPL
Tuesday, February 6, 2018, 10:59 AM — ETF Channel
Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View
Tuesday, February 6, 2018, 8:30 AM — Zacks
Bristol-Myers (BMY) Beats on Q4 Earnings, Eliquis Impresses
Monday, February 5, 2018, 1:24 PM — Zacks
Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft
Friday, February 2, 2018, 9:00 AM — Zacks
AstraZeneca (AZN) Beats on Q4 Earnings, Guides for 2018
Friday, February 2, 2018, 8:51 AM — Zacks
5 Top Earnings Growth Stocks to Buy in February
Friday, February 2, 2018, 7:57 AM — Zacks
Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings?
Friday, February 2, 2018, 7:16 AM — Zacks
5 Best Performing Stocks of January
Thursday, February 1, 2018, 8:33 AM — Zacks
Lilly (LLY) Beats on Q4 Earnings, Raises 2018 EPS Guidance
Wednesday, January 31, 2018, 10:29 AM — Zacks
Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View
Wednesday, January 31, 2018, 8:25 AM — Zacks
Drug/Biotech Stocks Q4 Earnings Due on Jan 31: LLY & VRTX
Tuesday, January 30, 2018, 5:06 PM — Zacks
Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors
Monday, January 29, 2018, 3:14 PM — Zacks
Roche Hemophilia Drug Hemlibra Gets Positive CHMP Opinion
Monday, January 29, 2018, 2:33 PM — Zacks
Notable ETF Inflow Detected - MTUM, BA, C, ABBV
Monday, January 29, 2018, 12:12 PM — ETF Channel
AstraZeneca's Triple Combo COPD Inhaler Positive in Phase III
Monday, January 29, 2018, 9:51 AM — Zacks
Stock Market News for Jan 29, 2018
Monday, January 29, 2018, 8:44 AM — Zacks
AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up
Friday, January 26, 2018, 11:09 AM — Zacks
A Spate of Q4 Earnings
Friday, January 26, 2018, 9:50 AM — Zacks
Q4 GDP Sub-3%, Q4 Earnings Roll On
Friday, January 26, 2018, 9:25 AM — Zacks
AbbVie (ABBV) Q4 Earnings & Revenues Beat, Guidance Raised
Friday, January 26, 2018, 8:37 AM — Zacks
Novartis Gets Spark Therapeutics' Luxterna License Outside US
Friday, January 26, 2018, 8:20 AM — Zacks
Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?
Friday, January 26, 2018, 8:10 AM — Zacks
Notable Thursday Option Activity: ASPS, ABBV, AMTD
Thursday, January 25, 2018, 3:17 PM — Stock Options Channel
Will Pfizer (PFE) Surpass Estimates This Earnings Season?
Thursday, January 25, 2018, 2:51 PM — Zacks
Why AbbVie (ABBV) Might Surprise This Earnings Season
Thursday, January 25, 2018, 7:52 AM — Zacks
See Which Of The Latest 13F Filers Holds AbbVie
Wednesday, January 24, 2018, 9:04 AM — Dividend Channel
Is a Beat in the Cards for AbbVie (ABBV) in Q4 Earnings?
Wednesday, January 24, 2018, 7:51 AM — Zacks
Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto
Wednesday, January 24, 2018, 6:42 AM — Zacks
Will Core Segmental Growth Aid Stryker (SYK) in Q4 Earnings?
Tuesday, January 23, 2018, 4:02 PM — Zacks
Novartis Announces Positive Results on Migraine Candidate
Tuesday, January 23, 2018, 3:37 PM — Zacks
3 Large Cap Pharma Stocks to Beat Earnings This Quarter
Tuesday, January 23, 2018, 11:48 AM — Zacks
J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve
Tuesday, January 23, 2018, 8:28 AM — Zacks
MTUM, BA, ABBV, MCD: Large Inflows Detected at ETF
Monday, January 22, 2018, 1:26 PM — ETF Channel
Healthcare ETFs to Watch As Q4 Earnings Unfold
Monday, January 22, 2018, 10:11 AM — Zacks
What's in the Cards for Varian Medical (VAR) in Q1 Earnings?
Monday, January 22, 2018, 9:34 AM — Zacks
What's in the Cards for Novartis (NVS) This Earnings Season?
Monday, January 22, 2018, 9:12 AM — Zacks
Amgen/Allergan's Avastin Biosimilar Secures EU Approval
Friday, January 19, 2018, 9:34 AM — Zacks
Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?
Thursday, January 18, 2018, 3:26 PM — Zacks
J&J (JNJ) Hits New 52-Week High: What's Driving the Stock?
Thursday, January 18, 2018, 8:26 AM — Zacks
Notable Wednesday Option Activity: ABBV, BPI, TGT
Wednesday, January 17, 2018, 3:37 PM — Stock Options Channel
AbbVie Named Top Dividend Stock With Insider Buying and 2.77% Yield (ABBV)
Wednesday, January 17, 2018, 11:29 AM — Dividend Channel
SPY, BA, DIS, ABBV: ETF Inflow Alert
Friday, January 12, 2018, 10:52 AM — ETF Channel
AbbVie Becomes #133 Most Shorted S&P 500 Component, Replacing Equity Residential
Thursday, January 11, 2018, 3:15 PM — Market News Video
Notable Tuesday Option Activity: MCK, ABBV, BIIB
Tuesday, January 9, 2018, 3:33 PM — Stock Options Channel
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Tuesday, January 9, 2018, 9:59 AM — Dividend Channel
General Electric Moves Up In Market Cap Rank, Passing AbbVie
Thursday, January 4, 2018, 5:04 PM — Market News Video
MTUM, BA, ABBV, ADBE: ETF Inflow Alert
Thursday, January 4, 2018, 11:12 AM — ETF Channel
ABBV Crosses Above Average Analyst Target
Thursday, January 4, 2018, 9:13 AM — ETF Channel
Notable Tuesday Option Activity: FDX, WM, ABBV
Tuesday, January 2, 2018, 1:36 PM — Stock Options Channel
Notable ETF Inflow Detected - VONE, DIS, ABBV, MCD
Wednesday, December 27, 2017, 11:05 AM — ETF Channel
First Week of August 2018 Options Trading For AbbVie (ABBV)
Tuesday, December 19, 2017, 11:43 AM — Stock Options Channel
Noteworthy ETF Inflows: VYM, ABBV, GILD, LLY
Friday, December 15, 2017, 11:01 AM — ETF Channel
AbbVie a Top Socially Responsible Dividend Stock With 3.0% Yield (ABBV)
Friday, December 15, 2017, 7:45 AM — ETF Channel
Noteworthy Friday Option Activity: UAL, GILD, ABBV
Friday, December 8, 2017, 2:13 PM — Stock Options Channel
VTI, CMCSA, BA, ABBV: ETF Inflow Alert
Thursday, December 7, 2017, 11:08 AM — ETF Channel
Notable Thursday Option Activity: MA, ABBV, ADP
Thursday, November 30, 2017, 3:23 PM — Stock Options Channel
iShares Russell Top 200 Growth ETF Experiences Big Outflow
Wednesday, November 29, 2017, 10:49 AM — ETF Channel
Notable ETF Inflow Detected - XLV, JNJ, PFE, ABBV
Friday, November 17, 2017, 10:47 AM — ETF Channel
XLV, MRK, ABBV, AMGN: ETF Outflow Alert
Thursday, November 9, 2017, 11:10 AM — ETF Channel
iShares Russell 1000 Growth ETF Experiences Big Inflow
Tuesday, October 31, 2017, 10:57 AM — ETF Channel
Notable Thursday Option Activity: PX, ABBV, DMRC
Thursday, October 26, 2017, 3:21 PM — Stock Options Channel
Notable ETF Inflow Detected - VHT, ABBV, AGN, DHR
Monday, October 23, 2017, 11:18 AM — ETF Channel
Notable Wednesday Option Activity: AGN, REGN, ABBV
Wednesday, October 18, 2017, 2:24 PM — Stock Options Channel
January 2020 Options Now Available For AbbVie
Monday, October 16, 2017, 11:29 AM — Stock Options Channel
IUSG, HD, ABBV, MA: ETF Inflow Alert
Friday, October 13, 2017, 11:05 AM — ETF Channel
AbbVie Reaches Analyst Target Price
Thursday, October 12, 2017, 9:01 AM — ETF Channel
Notable Wednesday Option Activity: ABBV, AGN, REGN
Wednesday, October 11, 2017, 1:33 PM — Stock Options Channel
Ex-Dividend Reminder: Foot Locker, Patterson Companies and AbbVie
Tuesday, October 10, 2017, 9:57 AM — Dividend Channel
IYY, ABBV, MMM, HON: Large Outflows Detected at ETF
Wednesday, October 4, 2017, 10:47 AM — ETF Channel
Noteworthy Thursday Option Activity: VLO, ABBV, ABT
Thursday, September 28, 2017, 1:22 PM — Stock Options Channel
Alliant Energy Becomes #192 Most Shorted S&P 500 Component, Replacing AbbVie
Wednesday, September 27, 2017, 2:48 PM — Market News Video
ABBV Dividend Yield Pushes Past 3%
Tuesday, September 26, 2017, 3:24 PM — Dividend Channel
Notable ETF Inflow Detected - ITOT, DWDP, ABBV, MMM
Tuesday, September 26, 2017, 11:01 AM — ETF Channel
AbbVie Named Top Dividend Stock With Insider Buying and 3.01% Yield (ABBV)
Tuesday, September 19, 2017, 11:12 AM — Dividend Channel
WisdomTree U.S. Quality Dividend Growth Fund Experiences Big Inflow
Monday, September 18, 2017, 11:04 AM — ETF Channel
Notable Friday Option Activity: ABBV, UAA, HOME
Friday, September 15, 2017, 3:24 PM — Stock Options Channel
Friday Sector Laggards: Healthcare, Utilities
Friday, September 15, 2017, 2:34 PM — Market News Video
Newell Brands Becomes #164 Most Shorted S&P 500 Component, Replacing AbbVie
Wednesday, September 13, 2017, 1:23 PM — Market News Video
AbbVie a Top Ranked SAFE Dividend Stock With 3.0% Yield (ABBV)
Monday, September 11, 2017, 7:40 AM — ETF Channel
Friday Sector Leaders: Financial, Healthcare
Friday, September 8, 2017, 3:12 PM — Market News Video
Notable Friday Option Activity: XL, ABBV, COST
Friday, September 8, 2017, 1:28 PM — Stock Options Channel
ABBV Crosses Above Average Analyst Target
Friday, September 8, 2017, 9:21 AM — ETF Channel
Thursday Sector Leaders: Healthcare, Utilities
Thursday, September 7, 2017, 2:34 PM — Market News Video
Vanguard High Dividend Yield ETF Experiences Big Inflow
Thursday, September 7, 2017, 10:54 AM — ETF Channel
Noteworthy ETF Inflows: IUSG, MA, MO, ABBV
Tuesday, August 29, 2017, 10:53 AM — ETF Channel
AbbVie Becomes #164 Most Shorted S&P 500 Component, Replacing Moody's Corp.
Friday, August 25, 2017, 2:43 PM — Market News Video
AbbVie Now #41 Largest Company, Surpassing Medtronic
Wednesday, August 23, 2017, 4:44 PM — Market News Video
iShares Russell 1000 Growth ETF Experiences Big Outflow
Monday, August 21, 2017, 11:12 AM — ETF Channel
RNDV's Underlying Holdings Could Mean 12% Gain Potential
Monday, August 21, 2017, 8:38 AM — ETF Channel
IWF, ABBV, CELG, AVGO: Large Outflows Detected at ETF
Friday, August 11, 2017, 10:46 AM — ETF Channel
The New #166 Most Shorted S&P 500 Component: ONEOK
Thursday, August 10, 2017, 3:25 PM — Market News Video
AbbVie Inc a Top 25 Dividend Giant With 3.56% Yield (ABBV)
Thursday, August 10, 2017, 9:55 AM — ETF Channel
Top Buys by Directors: Rapp's $281.8K Bet on ABBV
Thursday, August 3, 2017, 2:13 PM — Dividend Channel
Noteworthy ETF Outflows: VYM, PFE, MMM, ABBV
Tuesday, August 1, 2017, 11:53 AM — ETF Channel
Notable Friday Option Activity: MA, ABBV, APA
Friday, July 28, 2017, 2:27 PM — Stock Options Channel
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, July 26, 2017, 8:50 AM — ETF Channel
Noteworthy ETF Inflows: VYM, PFE, MMM, ABBV
Monday, July 24, 2017, 10:53 AM — ETF Channel
Notable ETF Inflow Detected - VHT, PFE, MDT, ABBV
Friday, July 14, 2017, 10:52 AM — ETF Channel
CME Group Becomes #137 Most Shorted S&P 500 Component, Replacing AbbVie
Thursday, July 13, 2017, 2:52 PM — Market News Video
Noteworthy Tuesday Option Activity: PH, YELP, ABBV
Tuesday, July 11, 2017, 3:36 PM — Stock Options Channel
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Monday, July 10, 2017, 10:00 AM — Dividend Channel
Vanguard High Dividend Yield ETF Experiences Big Outflow
Wednesday, July 5, 2017, 10:52 AM — ETF Channel
Target Becomes #125 Most Shorted S&P 500 Component, Replacing AbbVie
Tuesday, June 27, 2017, 2:41 PM — Market News Video
Health Care Select Sector SPDR Fund Experiences Big Inflow
Tuesday, June 27, 2017, 11:44 AM — ETF Channel
Noteworthy Thursday Option Activity: COST, ABBV, AET
Thursday, June 22, 2017, 2:33 PM — Stock Options Channel
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, June 21, 2017, 9:12 AM — ETF Channel
Commit To Purchase AbbVie At $40, Earn 2.5% Using Options
Tuesday, June 20, 2017, 11:34 AM — Stock Options Channel
Health Care Select Sector SPDR Fund Experiences Big Inflow
Monday, June 19, 2017, 10:55 AM — ETF Channel
AbbVie a Top Socially Responsible Dividend Stock With 3.6% Yield (ABBV)
Thursday, June 15, 2017, 7:22 AM — ETF Channel
PowerShares Dynamic Pharmaceuticals Portfolio Experiences Big Outflow
Friday, June 9, 2017, 10:45 AM — ETF Channel
Notable ETF Inflow Detected - VOO, BRK.B, V, ABBV
Thursday, June 1, 2017, 10:51 AM — ETF Channel
Notable Thursday Option Activity: ABBV, LB, GPS
Thursday, May 18, 2017, 1:34 PM — Stock Options Channel
SPHD's Holdings Imply 10% Gain Potential
Thursday, May 18, 2017, 9:06 AM — ETF Channel
Noteworthy ETF Inflows: DGRO, ABBV, MCD, MDT
Friday, May 12, 2017, 10:50 AM — ETF Channel
Notable Wednesday Option Activity: KORS, ABBV, LNG
Wednesday, May 10, 2017, 3:32 PM — Stock Options Channel
iShares Core Dividend Growth ETF Experiences Big Inflow
Thursday, May 4, 2017, 10:46 AM — ETF Channel
UPRO, MDT, MCD, ABBV: Large Outflows Detected at ETF
Wednesday, April 26, 2017, 10:50 AM — ETF Channel
ABBV is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

BDSI News
CYH News
USPH News
THRX News
IPCM News
HALO News
NKTR News
SPPI News
EXEL News
HSP News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AbbVie News | www.RediNews.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.